Artículos relacionados a Sustained Release Tablet of Itopride Hydrochloride:...
Sustained Release Tablet of Itopride Hydrochloride: Formulation, Development and In Vitro Evaluation Reduce Dosing Frequency by Once a Day Delivery - Tapa blanda
Sinopsis
Itopride, a novel prokinetic agent is unique and different from the available prokinetics because of its dual mode of action and lack of significant drug interaction potential. Itopride is a newly developed prokinetic agent, which enhances gastric motility through both anti-dopaminergic and anti-acetylcholinesterage actions. It is best candidate for Gastro Esophageal Reflux Disease. Itopride 50mg can be given thrice in a day for Treatment of GERD. By developing the sustain release formulation of Itopride hydrochloride, the frequency of drug can be reduce to once only to obtain good therapeutic response. The prepared formulation is usually taken on an empty stomach about an hour before meals. Sustained release tablet of Itopride Hydrochloride was prepared by using combination of HPMC grade as matrix forming material. The influence of amount of Hydroxypropyl Methylcellulose K15M and Hydroxypropyl Methylcellulose K100M on release of Itopride hydrochloride was studied using Central composite design. The optimized Formulation FB7 had given prolonged drug release up to 24 hr. It also had desired drug release kinetics and it was found to be stable after 1 month at accelerated conditions.
"Sinopsis" puede pertenecer a otra edición de este libro.
Acerca del autor
Mr. Pankil A. Gandhi has completed M.Pharm. degree in specialization (pharmaceutics) from Shri B.M.Shah College of Pharmaceutical Education and Research, Modasa affiliated to Gujarat Technological University, Gujarat, India in 2012.He is the author of several published articles in international pharmaceutical journals.
"Sobre este título" puede pertenecer a otra edición de este libro.
EUR 60,92
EUR 17,05 gastos de envío desde Estados Unidos de America a España
Destinos, gastos y plazos de envíoComprar nuevo
Ver este artículo
EUR 57,02
EUR 4,66 gastos de envío desde Reino Unido a España
Destinos, gastos y plazos de envíoResultados de la búsqueda para Sustained Release Tablet of Itopride Hydrochloride:...
Imagen de archivo
Sustained Release Tablet of Itopride Hydrochloride: Formulation, Development and In Vitro Evaluation Reduce Dosing Frequency by Once a Day Delivery
Publicado por
LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659151505
ISBN 13: 9783659151507
Nuevo
Tapa blanda
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: New. In. Nº de ref. del artículo: ria9783659151507_new
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Sustained Release Tablet of Itopride Hydrochloride Formulation, Development and In Vitro Evaluation Reduce Dosing Frequency by Once a Day Delivery
Publicado por
LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659151505
ISBN 13: 9783659151507
Nuevo
PAP
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
PAP. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Nº de ref. del artículo: L0-9783659151507
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Sustained Release Tablet of Itopride Hydrochloride Formulation, Development and In Vitro Evaluation Reduce Dosing Frequency by Once a Day Delivery
Publicado por
LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659151505
ISBN 13: 9783659151507
Nuevo
PAP
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
PAP. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Nº de ref. del artículo: L0-9783659151507
Cantidad disponible: Más de 20 disponibles
Imagen del vendedor
Sustained Release Tablet of Itopride Hydrochloride
Publicado por
LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659151505
ISBN 13: 9783659151507
Nuevo
Tapa blanda
Librería: moluna, Greven, Alemania
Calificación del vendedor: 5 de 5 estrellas
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Gandhi PankilMr. Pankil A. Gandhi has completed M.Pharm. degree in specialization (pharmaceutics) from Shri B.M.Shah College of Pharmaceutical Education and Research, Modasa affiliated to Gujarat Technological University, Gujarat, In. Nº de ref. del artículo: 5135231
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Sustained Release Tablet of Itopride Hydrochloride: Formulation, Development and In Vitro Evaluation Reduce Dosing Frequency by Once a Day Delivery
Publicado por
LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659151505
ISBN 13: 9783659151507
Nuevo
Tapa blanda
Librería: California Books, Miami, FL, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Condición: New. Nº de ref. del artículo: I-9783659151507
Cantidad disponible: Más de 20 disponibles
Imagen del vendedor
Sustained Release Tablet of Itopride Hydrochloride
Publicado por
LAP LAMBERT Academic Publishing Jun 2012, 2012
ISBN 10: 3659151505
ISBN 13: 9783659151507
Nuevo
Taschenbuch
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Calificación del vendedor: 5 de 5 estrellas
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Itopride, a novel prokinetic agent is unique and different from the available prokinetics because of its dual mode of action and lack of significant drug interaction potential. Itopride is a newly developed prokinetic agent, which enhances gastric motility through both anti-dopaminergic and anti-acetylcholinesterage actions. It is best candidate for Gastro Esophageal Reflux Disease. Itopride 50mg can be given thrice in a day for Treatment of GERD. By developing the sustain release formulation of Itopride hydrochloride, the frequency of drug can be reduce to once only to obtain good therapeutic response. The prepared formulation is usually taken on an empty stomach about an hour before meals. Sustained release tablet of Itopride Hydrochloride was prepared by using combination of HPMC grade as matrix forming material. The influence of amount of Hydroxypropyl Methylcellulose K15M and Hydroxypropyl Methylcellulose K100M on release of Itopride hydrochloride was studied using Central composite design. The optimized Formulation FB7 had given prolonged drug release up to 24 hr. It also had desired drug release kinetics and it was found to be stable after 1 month at accelerated conditions. 128 pp. Englisch. Nº de ref. del artículo: 9783659151507
Cantidad disponible: 2 disponibles
Imagen del vendedor
Sustained Release Tablet of Itopride Hydrochloride : Formulation, Development and In Vitro Evaluation Reduce Dosing Frequency by Once a Day Delivery
Publicado por
LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659151505
ISBN 13: 9783659151507
Nuevo
Taschenbuch
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Calificación del vendedor: 5 de 5 estrellas
Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Itopride, a novel prokinetic agent is unique and different from the available prokinetics because of its dual mode of action and lack of significant drug interaction potential. Itopride is a newly developed prokinetic agent, which enhances gastric motility through both anti-dopaminergic and anti-acetylcholinesterage actions. It is best candidate for Gastro Esophageal Reflux Disease. Itopride 50mg can be given thrice in a day for Treatment of GERD. By developing the sustain release formulation of Itopride hydrochloride, the frequency of drug can be reduce to once only to obtain good therapeutic response. The prepared formulation is usually taken on an empty stomach about an hour before meals. Sustained release tablet of Itopride Hydrochloride was prepared by using combination of HPMC grade as matrix forming material. The influence of amount of Hydroxypropyl Methylcellulose K15M and Hydroxypropyl Methylcellulose K100M on release of Itopride hydrochloride was studied using Central composite design. The optimized Formulation FB7 had given prolonged drug release up to 24 hr. It also had desired drug release kinetics and it was found to be stable after 1 month at accelerated conditions. Nº de ref. del artículo: 9783659151507
Cantidad disponible: 1 disponibles
Imagen del vendedor
Sustained Release Tablet of Itopride Hydrochloride
Publicado por
LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659151505
ISBN 13: 9783659151507
Nuevo
Tapa blanda
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Condición: New. Nº de ref. del artículo: 18427285-n
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Sustained Release Tablet of Itopride Hydrochloride: Formulation, Development and In Vitro Evaluation Reduce Dosing Frequency by Once a Day Delivery
Publicado por
LAP LAMBERT Academic Publishing 2012-06-07, 2012
ISBN 10: 3659151505
ISBN 13: 9783659151507
Nuevo
Paperback
Librería: Chiron Media, Wallingford, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Paperback. Condición: New. Nº de ref. del artículo: 6666-IUK-9783659151507
Cantidad disponible: 10 disponibles
Imagen del vendedor
Sustained Release Tablet of Itopride Hydrochloride
Publicado por
LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659151505
ISBN 13: 9783659151507
Nuevo
Tapa blanda
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: New. Nº de ref. del artículo: 18427285-n
Cantidad disponible: Más de 20 disponibles